Mealey's (January 18, 2022, 2:24 PM EST) -- NEW YORK — A New York federal judge on Jan. 14 found that former pharmaceutical executive Martin Shkreli engaged in anticompetitive conduct in his marketing of the antiparasitic drug Daraprim, ordered him barred for life from working in the drug industry and ordered him to disgorge $64 million in net profits from his monopolistic actions....